We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Court Affirms Amgen Repatha Patents in Dispute With Regeneron, Sanofi
Federal Court Affirms Amgen Repatha Patents in Dispute With Regeneron, Sanofi
In a loss for Sanofi and Regeneron, a federal judge upheld a jury verdict validating two of Amgen’s cholesterol drug patents for Repatha, denying a request to overturn the judgment and launch a new trial.